ArticleAmerican journal of clinical and experimental urology2025

RB1 and p53 are diagnostic markers for treatment-related neuroendocrine prostate cancer: a clinical and pathological analysis of 23 cases.

Yutao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.